Skip to main content

NUEVAS HERRAMIENTAS MOLECULARES FRENTE A VIRUS RNA PATOGENOS: DESARROLLO DE APTAMEROS INHIBIDORES DEL VHC Y DEL VIH.

BIO2013-47228-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chemical roots of biological evolution: the origins of life as a process of development of autonomous functional systems

  • Ruiz-Mirazo, Kepa
  • Briones, Carlos
  • Escosura, Andrés de la
In recent years, an extension of the Darwinian framework is being considered for the study of prebiotic chemical evolution, shifting the attention from homogeneous populations of naked molecular species to populations of heterogeneous, compartmentalized and functionally integrated assemblies of molecules. Several implications of this shift of perspective are analysed in this critical review, both in terms of the individual units, which require an adequate characterization as self-maintaining systems with an internal organization, and also in relation to their collective and long-term evolutionary dynamics, based on competition, collaboration and selection processes among those complex individuals. On these lines, a concrete proposal for the set of molecular control mechanisms that must be coupled to bring about autonomous functional systems, at the interface between chemistry and biology, is provided., K.R.-M.'s research activity received support from the Basque Government (grant no. IT 590-13) and from the Spanish Ministry of Economía y Competitividad (MINECO, grant no. FFI2014-52173-P). C.B. acknowledges funding from the Spanish MINECO (grant nos. BIO2013-47228-R and BIO2016-79618-R). A.d.l.E., a Ramón y Cajal Research Fellow, received support from the Spanish MINECO (grant no. CTQ-2014-53673-P). The authors also thank the interdisciplinary framework provided by COST Actions CM1304 (Emergence and evolution of complex chemical systems) and TD1308 (Origins and evolution of life on Earth and in the Universe)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies

  • Martín, Verónica|||0000-0003-1486-1656
  • Perales Viejo, Celia|||0000-0003-1618-1937
  • Fernández-Algar, María
  • Dos Santos, Helena G.
  • Garrido, Patricia
  • Pernas, María
  • Parro, Víctor
  • Moreno, Miguel
  • García-Pérez, Javier|||0000-0003-0300-1810
  • Alcami, Jose|||0000-0003-0023-7377
  • Torán, José Luis
  • Abia, David|||0000-0003-0401-7590
  • Domingo, Esteban
  • Briones Llorente, Carlos|||0000-0003-2213-8353
The response of human immunodeficiency virus type 1 (HIV-1) quasispecies to antiretroviral therapy is influenced by the ensemble of mutants that composes the evolving population. Low-abundance subpopulations within HIV-1 quasispecies may determine the viral response to the administered drug combinations. However, routine sequencing assays available to clinical laboratories do not recognize HIV-1 minority variants representing less than 25% of the population. Although several alternative and more sensitive genotyping techniques have been developed, including next-generation sequencing (NGS) methods, they are usually very time consuming, expensive and require highly trained personnel, thus becoming unrealistic approaches in daily clinical practice. Here we describe the development and testing of a HIV-1 genotyping DNA microarray that detects and quantifies, in majority and minority viral subpopulations, relevant mutations and amino acid insertions in 42 codons of the pol gene associated with drug- and multidrug-resistance to protease (PR) and reverse transcriptase (RT) inhibitors. A customized bioinformatics protocol has been implemented to analyze the microarray hybridization data by including a new normalization procedure and a stepwise filtering algorithm, which resulted in the highly accurate (96.33%) detection of positive/negative signals. This microarray has been tested with 57 subtype B HIV-1 clinical samples extracted from multi-treated patients, showing an overall identification of 95.53% and 89.24% of the queried PR and RT codons, respectively, and enough sensitivity to detect minority subpopulations representing as low as 5-10% of the total quasispecies. The developed genotyping platform represents an efficient diagnostic and prognostic tool useful to personalize antiviral treatments in clinical practice.